Sleiman, S. F., Langley, B. C., Basso, M., Berlin, J., Xia, L., Payappilly, J. B., . . . Ratan, R. R. (2011). Mithramycin Is a Gene-Selective Sp1 Inhibitor That Identifies a Biological Intersection between Cancer and Neurodegeneration. Society for Neuroscience.
استشهاد بنمط شيكاغوSleiman, Sama F., et al. Mithramycin Is a Gene-Selective Sp1 Inhibitor That Identifies a Biological Intersection between Cancer and Neurodegeneration. Society for Neuroscience, 2011.
MLA استشهادSleiman, Sama F., et al. Mithramycin Is a Gene-Selective Sp1 Inhibitor That Identifies a Biological Intersection between Cancer and Neurodegeneration. Society for Neuroscience, 2011.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.